| Tarsons Products Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 543399 |
NSE Symbol : TARSONS |
P/E(TTM) : 87.68 |
|
ISIN Demat : INE144Z01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.88 |
|
Book Value(₹) : 126.98 |
Market Cap(₹Cr) : 1,810.08 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 86.15 | 97.16 | 83.99 | 80.51 | 71.28 | 93.04 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 86.15 | 97.16 | 83.99 | 80.51 | 71.28 | 93.04 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.75 | 7.64 | 9.71 | 7.32 | 4.58 | 6.37 |
| Total Income | 92.90 | 104.79 | 93.70 | 87.82 | 75.86 | 99.42 |
| Total Expenditure | 61.98 | 64.58 | 56.20 | 54.36 | 49.05 | 56.08 |
| PBIDT | 30.92 | 40.21 | 37.50 | 33.46 | 26.81 | 43.34 |
| Interest | 5.44 | 5.41 | 5.32 | 4.41 | 4.28 | 4.52 |
| PBDT | 25.48 | 34.80 | 32.18 | 29.05 | 22.53 | 38.82 |
| Depreciation | 24.56 | 26.70 | 22.65 | 20.17 | 17.75 | 17.48 |
| Tax | 0.18 | 0.94 | 2.36 | 2.23 | 1.17 | 6.41 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.06 | 1.70 | 0.08 | 0.12 | 0.03 | -0.79 |
| Reported Profit After Tax | 0.68 | 5.46 | 7.09 | 6.53 | 3.57 | 15.73 |
| Extra-ordinary Items | 0.00 | 0.15 | -1.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.68 | 5.31 | 8.09 | 6.53 | 3.57 | 15.73 |
| EPS (Unit Curr.) | 0.13 | 1.03 | 1.33 | 1.23 | 0.67 | 2.96 |
| EPS (Adj) (Unit Curr.) | 0.13 | 1.03 | 1.33 | 1.23 | 0.67 | 2.96 |
| Calculated EPS (Unit Curr.) | 0.13 | 1.03 | 1.33 | 1.23 | 0.67 | 2.96 |
| Calculated EPS (Adj) (Unit Curr.) | 0.13 | 1.03 | 1.33 | 1.23 | 0.67 | 2.96 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.51 | 4.11 | 5.33 | 4.91 | 2.68 | 11.83 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.51 | 4.11 | 5.33 | 4.91 | 2.68 | 11.83 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.89 | 41.39 | 44.65 | 41.56 | 37.61 | 46.58 |
| PBDTM(%) | 29.58 | 35.82 | 38.31 | 36.08 | 31.61 | 41.72 |
| PATM(%) | 0.79 | 5.62 | 8.44 | 8.11 | 5.01 | 16.91 |
